Hypoxia-inducible factor-1alpha (HIF-1α) has been considered as a regulator of both prosurvival and prodeath pathways in the nervous system. The present study was designed to elucidate the role of HIF-1α in neonatal hypoxic-ischemic (HI) brain injury. Rice-Vannucci model of neonatal hypoxic-ischemic brain injury was used in seven-day-old rats, by subjecting unilateral carotid artery ligation followed by 2 h of hypoxia (8% O 2 at 37°C). HIF-1α activity was inhibited by 2-methoxyestradiol (2ME2) and enhanced by dimethyloxalylglycine (DMOG). Results showed that 2ME2 exhibited dose-dependent neuroprotection by decreasing infarct volume and reducing brain edema at 48 h post HI. The neuroprotection was lost when 2ME2 was administered 3 h post HI. HIF-1α upregulation by DMOG increased the permeability of the BBB and brain edema compared with HI group. 2ME2 attenuated the increase in HIF-1α and VEGF 24 h after HI. 2ME2 also had a long-term effect of protecting against the loss of brain tissue. The study showed that the early inhibition of HIF-1α acutely after injury provided neuroprotection after neonatal hypoxia-ischemia which was associated with preservation of BBB integrity, attenuation of brain edema, and neuronal death.
Introduction
Perinatal hypoxic-ischemic brain injury is a major cause of morbidity and mortality in infants and children, with a reported incidence of 2-9 per 1000 births (Vannucci, 1990; Gomella, 1999) . Furthermore, 20-50% of the infants suffering from hypoxic-ischemic encephalopathy died during the newborn period and up to 25% suffered permanent brain damage (Vannucci et al., 1999) .
Hypoxia-inducible factor 1α (HIF-1α) is an important transcriptional factor implicated in many cerebrovascular pathological disorders (Semenza, 2001) . Several critical signaling proteins and enzymes, such as cyclooxygenase-2, inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and erythropoietin, are known to be target genes of HIF-1α (Ran et al., 2005) .
HIF-1α upregulation by preconditioning paradigms with hypoxia and other known preconditioning agents such as deferoxamine and cobalt chloride has been suggested to be neuroprotective after cerebral ischemic injury (Kerendi et al., 2005; Sharp et al., 2004; Jones et al., 2006; Ran et al., 2005; Mu et al., 2003; Bergeron et al., 2000) . HIF-1α, however, is also known to be increased by cerebral ischemia itself. The effects of HIF-1α manipulation by post-treatment have only recently started gathering interest. Recent reports have suggested that HIF-1α inhibition after cerebral ischemia imparts neuroprotection in adult experimental models (Chang et al., 2007; Chen et al., 2007) . A study of brain-specific knockouts of HIF-1α in mice after hypoxic injury suggested that HIF-1α is implicated in brain damage and decreasing the level of HIF-1α could be neuroprotective (Helton et al., 2005) . Thus, HIF-1α seems to be capable of playing a dual role by activating both pro-death and antiapoptotic pathways (Chang et al., 2007; Chen et al., 2007; Baranova et al., 2007; Helton et al., 2005) . Baranova et al. have recently shown a biphasic time course for the regulation of HIF-1α activation after cerebral ischemia (Baranova et al., 2007) . The first phase activation occurred acutely after injury lasted 12 h and was involved with the upregulation of mostly pro-death HIF-1α target genes. In contrast, these genes remained unchanged during the second phase of HIF-1 α activation, beginning at 24 h and lasting up to 10 days. Thus, acute inhibition of HIF-1α is likely to be beneficial in cerebral ischemic injuries.
The present study was designed to clarify the role of HIF-1α in the neonatal brain after hypoxic-ischemic insult. We hypothesized that acute inhibition of HIF-1α provides neuroprotection against neonatal hypoxia-ischemia (HI). 2-methoxyestradiol (2ME2) is an estradiol derivative and a known HIF-1α inhibitor (Mabjeesh et al., 2003; Neurobiology of Disease 31 (2008) [433] [434] [435] [436] [437] [438] [439] [440] [441] 
